MAIA Biotechnology Inc’s filing revealed that its Director Smith Stan acquired Company’s shares for reported $50000.0 on Jun 03 ’25. In the deal valued at $1.50 per share,33,333 shares were bought. As a result of this transaction, Smith Stan now holds 1,305,059 shares worth roughly $2.23 million.
Then, Guerrero Ramiro bought 20,000 shares, generating $30,000 in total proceeds. Upon buying the shares at $1.50, the Director now owns 588,218 shares.
Before that, Smith Stan bought 66,666 shares. MAIA Biotechnology Inc shares valued at $99,999 were divested by the Director at a price of $1.50 per share. As a result of the transaction, Smith Stan now holds 1,271,726 shares, worth roughly $2.17 million.
Price Performance Review of MAIA
On Tuesday, MAIA Biotechnology Inc [AMEX:MAIA] saw its stock fall -3.93% to $1.71. Over the last five days, the stock has lost -7.07%. MAIA Biotechnology Inc shares have fallen nearly -55.24% since the year began. Nevertheless, the stocks have fallen -13.64% over the past one year. While a 52-week high of $4.24 was reached on 05/02/25, a 52-week low of $1.40 was recorded on 04/10/25.
Levels Of Support And Resistance For MAIA Stock
The 24-hour chart illustrates a support level at 1.6749, which if violated will result in even more drops to 1.6398. On the upside, there is a resistance level at 1.7552. A further resistance level may holdings at 1.8004.
How much short interest is there in MAIA Biotechnology Inc?
A steep rise in short interest was recorded in MAIA Biotechnology Inc stocks on 2025-06-13, dropping by -0.17 million shares to a total of 0.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.56 million shares. There was a decline of -42.51%, which implies that there is a negative sentiment for the stock.
